(Q38320192)

2 September 2017

title

Hepatoprotective effect of DT56a is associated with changes in natural killer T cells and regulatory T cells (English)

1 reference

2 September 2017

Yehudit Shabat

1

1 reference

2 September 2017

Yoav Lichtenstein

2

1 reference

2 September 2017

Lydya Zolotarov

3

1 reference

2 September 2017

Ami Ben Ya'acov

4

1 reference

2 September 2017

Yaron Ilan

5

1 reference

2 September 2017

publication date

1 February 2013

1 reference

Journal of Digestive Diseases

2 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

2 September 2017

volume

14

1 reference

2 September 2017

issue

2

1 reference

2 September 2017

page(s)

84-92

1 reference

Microanatomy of the liver immune system.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

The liver as a lymphoid organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Early intrahepatic accumulation of CD8+ T cells provides a source of effectors for nonhepatic immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Immunology of the gut and liver: a love/hate relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

21 January 2018

The biology of NKT cells

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Working with NKT cells--pitfalls and practicalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

DT56a (Femarelle): a natural selective estrogen receptor modulator (SERM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

DT56a (Femarelle) stimulates bone formation in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

DT56a stimulates creatine kinase specific activity in vascular tissues of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

DT56a (Tofupill/Femarelle) selectively stimulates creatine kinase specific activity in skeletal tissues of rats but not in the uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Efficacy of isoflavones in relieving vasomotor menopausal symptoms - A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Soy consumption for reduction of menopausal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Normalization of obesity-associated insulin resistance through immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Overexpression of suppressor of cytokine signaling-3 in T cells exacerbates acetaminophen-induced hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Glucocerebroside ameliorates the metabolic syndrome in OB/OB mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Beta-glycoglycosphingolipid-induced alterations of the STAT signaling pathways are dependent on CD1d and the lipid raft protein flotillin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Beta-glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Glucocerebroside: an evolutionary advantage for patients with Gaucher disease and a new immunomodulatory agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Beta-glycosphingolipids-mediated lipid raft alteration is associated with redistribution of NKT cells and increased intrahepatic CD8+ T lymphocyte trapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Modulation of intracellular machinery by beta-glycolipids is associated with alteration of NKT lipid rafts and amelioration of concanavalin-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Th1/Th2 cytokine balance as a determinant of acetaminophen-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

The gut mucosa as a site for induction of regulatory T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Oral tolerance: can we make it work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

DT56a stimulates gender-specific human cultured bone cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Pharmacological doses of the natural phyto-SERM DT56a (Femarelle) have no effect on MCF-7 human breast cancer cell-line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Obesity predisposes to Th17 bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Inflammation and endoplasmic reticulum stress in obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Nutrient sensing and inflammation in metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Stressing the brain, fattening the body.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Role of the NF-kappaB axis in immune modulation of osteoclasts and bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

IL-27 abrogates receptor activator of NF-kappa B ligand-mediated osteoclastogenesis of human granulocyte-macrophage colony-forming unit cells through STAT1-dependent inhibition of c-Fos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Postmenopausal expression changes of immune system-related genes in human bone tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Mucosal immunity in the human female reproductive tract: cytotoxic T lymphocyte function in the cervix and vagina of premenopausal and postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12003

21 January 2018

Identifiers

DOI

10.1111/1751-2980.12003

1 reference

2 September 2017

1 reference